IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines-Reference-Cited by-同舟云学术

IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines

Published:2017-01-20 Issue:11 Volume:66 Page:1815-1816
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Murri Rita¹,Taccari Francesco¹,Palazzolo Claudia¹,Fantoni Massimo¹,Cauda Roberto¹

Affiliation:

1. Institute of Infectious Diseases, Catholic University of Rome, Italy

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/66/11/1815/24818041/cix1114.pdf

Reference6 articles.

1. IDSA position statement: why IDSA did not endorse the surviving sepsis campaign guidelines [manuscript published online ahead of print 22 November 2017];Gilbert;Clin Infect Dis,2018

2. The Third International Consensus definitions for sepsis and septic shock (Sepsis-3);Singer;JAMA,2016

3. Assessment of clinical criteria for sepsis: for the Third International Consensus definitions for sepsis and septic shock (Sepsis-3);Seymour;JAMA,2016

4. Assessment of definition and clinical criteria for septic shock;Shankar-Hari;JAMA,2016

5. Systemic inflammatory response syndrome criteria for severe sepsis;Kaukonen;N Engl J Med,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bloodstream infection: Derivation and validation of a reliable and multidimensional prognostic score based on a machine learning model (BLISCO);American Journal of Infection Control;2024-07

2. Impact of 1-Hour Bundle Achievement in Septic Shock;Journal of Clinical Medicine;2021-02-02

3. Maternal sepsis;American Journal of Obstetrics & Gynecology MFM;2020-08

4. Antimicrobial De-Escalation in the ICU: From Recommendations to Level of Evidence;Advances in Therapy;2020-05-27

5. Pharmacological management of sepsis in adults with a focus on the current gold standard treatments and promising adjunctive strategies: evidence from the last five years;Expert Opinion on Pharmacotherapy;2019-03-17